Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
ECOR1 CAPITAL LLC | 05-13-2024 | 03-31-2024 | 59 | 3,953,710,314 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
ARCUTIS BIOTHERAPEUTICS INC | COM | 101 | $4,955,000 | 500,000 | 0.00 | 500,000 | +Inf | 03-31-2024 | |
PRIME MEDICINE INC | COM | 102 | $4,900,000 | 700,000 | 0.00 | 0.00 | 100,000 | 16.67 | 03-31-2024 |
PRELUDE THERAPEUTICS INC | COM | Liquidated | $0 | 0 | 0.00 | 0.00 | 0 | 0.00 | 03-31-2024 |
NUVATION BIO INC | *W EXP 07/07/202 | 104 | $3,506,532 | 963,333 | 0.00 | 0.00 | 0 | 0.00 | 03-31-2024 |